Thomas Uhde to Humans
This is a "connection" page, showing publications Thomas Uhde has written about Humans.
Connection Strength
0.689
-
Perinatal Sleep Problems: Causes, Complications, and Management. Obstet Gynecol Clin North Am. 2018 Sep; 45(3):483-494.
Score: 0.024
-
Preliminary evidence for differential olfactory and trigeminal processing in combat veterans with and without PTSD. Neuroimage Clin. 2018; 17:378-387.
Score: 0.022
-
Burning odor-elicited anxiety in OEF/OIF combat veterans: Inverse relationship to gray matter volume in olfactory cortex. J Psychiatr Res. 2015 Nov; 70:58-66.
Score: 0.019
-
Differential odor sensitivity in PTSD: Implications for treatment and future research. J Affect Disord. 2015 Jul 01; 179:23-30.
Score: 0.019
-
Excess health care service utilization and costs associated with underrecognition of psychiatric comorbidity in a medical/surgical inpatient setting. Qual Manag Health Care. 2011 Apr-Jun; 20(2):98-102.
Score: 0.014
-
Anxiety and sleep problems: emerging concepts and theoretical treatment implications. Curr Psychiatry Rep. 2009 Aug; 11(4):269-76.
Score: 0.013
-
Cataplexy in anxious patients: is subclinical narcolepsy underrecognized in anxiety disorders? J Clin Psychiatry. 2009 Jun; 70(6):810-6.
Score: 0.012
-
Nocturnal sleep panic and depression: relationship to subjective sleep in panic disorder. J Affect Disord. 2009 Jan; 112(1-3):262-6.
Score: 0.012
-
Immobilization panic. Am J Psychiatry. 2006 Aug; 163(8):1453-4.
Score: 0.010
-
Twenty-four hour growth hormone secretion in patients with panic disorder. Psychoneuroendocrinology. 2005 Jan; 30(1):72-9.
Score: 0.009
-
Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder. A preliminary report. Neuropsychobiology. 2004; 49(2):53-7.
Score: 0.009
-
Linear and nonlinear measures of blood pressure variability: increased chaos of blood pressure time series in patients with panic disorder. Depress Anxiety. 2004; 19(2):85-95.
Score: 0.009
-
Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res. 2003 Dec 01; 121(2):185-96.
Score: 0.009
-
Sleep panic attacks: a micro-movement analysis. Depress Anxiety. 2003; 18(4):214-20.
Score: 0.008
-
Skin picking and sleep disturbances: relationship to anxiety and need for research. Depress Anxiety. 2003; 18(4):228-32.
Score: 0.008
-
Electrical stimulation of the trigeminal nerve improves olfaction in healthy individuals: A randomized, double-blind, sham-controlled trial. Brain Stimul. 2022 May-Jun; 15(3):761-768.
Score: 0.008
-
Anxiety-related shifts in smell function in children and adolescents. Chem Senses. 2021 01 01; 46.
Score: 0.007
-
Genetics and brain function: implications for the treatment of anxiety. Biol Psychiatry. 2000 Dec 15; 48(12):1142-3.
Score: 0.007
-
Convergent, discriminant, and criterion-related validity of the Social Phobia and Anxiety Inventory. Depress Anxiety. 2000; 11(1):10-4.
Score: 0.007
-
Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program. J Subst Abuse Treat. 2019 09; 104:97-103.
Score: 0.006
-
Exploratory Investigation of a Brief Cognitive Behavioral Intervention and Transcranial Direct Current Stimulation on Odor Sensitivity. Psychosom Med. 2019 05; 81(4):389-395.
Score: 0.006
-
Web-based CBT for the prevention of anxiety symptoms among medical and health science graduate students. Cogn Behav Ther. 2019 09; 48(5):385-405.
Score: 0.006
-
Odor sensitivity impairment: a behavioral marker of psychological distress? CNS Spectr. 2019 08; 24(4):404-412.
Score: 0.006
-
The relationship between plasma MHPG and NE: employing regression models in estimating centrally derived MHPG and peripheral NE turnover rate in panic disorder. J Psychiatr Res. 1998 Jan-Feb; 32(1):11-7.
Score: 0.006
-
Trauma management therapy with virtual-reality augmented exposure therapy for combat-related PTSD: A randomized controlled trial. J Anxiety Disord. 2019 01; 61:64-74.
Score: 0.006
-
Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatry Res. 1997 Jun 16; 71(1):27-39.
Score: 0.005
-
A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls. Neuropsychopharmacology. 1997 Mar; 16(3):229-37.
Score: 0.005
-
Role of serotonin drugs in the treatment of social phobia. J Clin Psychiatry. 1997; 58 Suppl 5:50-4.
Score: 0.005
-
Rapid onset: a valid panic disorder criterion? Depress Anxiety. 1997; 5(3):121-6.
Score: 0.005
-
An examination of sleep quality in veterans with a dual diagnosis of PTSD and severe mental illness. Psychiatry Res. 2017 Jan; 247:15-20.
Score: 0.005
-
Depression-Specific Outcomes After Treatment of Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2016 Apr; 142(4):370-6.
Score: 0.005
-
Depression in chronic rhinosinusitis: A controlled cohort study. Am J Rhinol Allergy. 2016 Mar-Apr; 30(2):128-33.
Score: 0.005
-
What looks good and is good for you? The Journal Depression and Anxiety. Anxiety. 1996; 2(6):255.
Score: 0.005
-
The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults. Psychiatry Res. 2015 Dec 30; 234(3):321-7.
Score: 0.005
-
Psychiatric characteristics of children with selective mutism: a pilot study. J Am Acad Child Adolesc Psychiatry. 1995 Jul; 34(7):847-56.
Score: 0.005
-
Oscillating Square Wave Transcranial Direct Current Stimulation (tDCS) Delivered During Slow Wave Sleep Does Not Improve Declarative Memory More Than Sham: A Randomized Sham Controlled Crossover Study. Brain Stimul. 2015 May-Jun; 8(3):528-34.
Score: 0.005
-
Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study. J Psychiatr Res. 2014 Dec; 59:101-7.
Score: 0.005
-
Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1994 Sep; 33(7):1000-6.
Score: 0.005
-
Olfactory cue reactivity in nicotine-dependent adult smokers. Psychol Addict Behav. 2015 Mar; 29(1):91-6.
Score: 0.005
-
Anxiety and growth disturbance: is there a connection? A review of biological studies in social phobia. J Clin Psychiatry. 1994 Jun; 55 Suppl:17-27.
Score: 0.004
-
The sleep architecture of social phobia. Biol Psychiatry. 1994 Mar 15; 35(6):420-1.
Score: 0.004
-
Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. J Affect Disord. 1994 Mar; 30(3):155-61.
Score: 0.004
-
Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls. Anxiety. 1994-1995; 1(3):138-40.
Score: 0.004
-
Dose-response effects of intravenous caffeine in normal volunteers. Anxiety. 1994-1995; 1(4):161-8.
Score: 0.004
-
Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers. Anxiety. 1994-1995; 1(6):258-67.
Score: 0.004
-
Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry. 1993 Nov 01; 34(9):591-5.
Score: 0.004
-
Lack of efficacy of the adenosine reuptake inhibitor dipyridamole in the treatment of anxiety disorders. Biol Psychiatry. 1993 Apr 15-May 1; 33(8-9):647-50.
Score: 0.004
-
Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder. Am J Psychiatry. 1993 Feb; 150(2):336-7.
Score: 0.004
-
Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry. 1992 Nov; 31(6):1090-4.
Score: 0.004
-
Diurnal rhythms and symptom severity in panic disorder. A preliminary study of 24-hour changes in panic attacks, generalised anxiety, and avoidance behaviour. Br J Psychiatry. 1992 Oct; 161:512-6.
Score: 0.004
-
Acute dystonia and fluoxetine. J Clin Psychiatry. 1992 Sep; 53(9):327.
Score: 0.004
-
The National Institute of Mental Health Panic Questionnaire. An instrument for assessing clinical characteristics of panic disorder. J Nerv Ment Dis. 1992 Sep; 180(9):566-72.
Score: 0.004
-
Quantitative electroencephalographic effects of caffeine in panic disorder. Psychiatry Res. 1992 Aug; 45(2):105-13.
Score: 0.004
-
Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects. Arch Gen Psychiatry. 1992 Apr; 49(4):311-7.
Score: 0.004
-
Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Neuropsychopharmacology. 1992 Feb; 6(2):101-18.
Score: 0.004
-
An examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder. J Clin Psychiatry. 1992 Jan; 53(1):23-7.
Score: 0.004
-
Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. Biol Psychiatry. 1991 Nov 15; 30(10):973-84.
Score: 0.004
-
Phenomenology and neurobiology of social phobia: comparison with panic disorder. J Clin Psychiatry. 1991 Nov; 52 Suppl:31-40.
Score: 0.004
-
Hypothalamic-pituitary-adrenocortical activity in panic disorder: relationship to plasma catecholamine metabolites. Biol Psychiatry. 1991 Sep 01; 30(5):502-6.
Score: 0.004
-
The QKd interval in panic disorder: an assessment of end-organ thyroid hormone responsivity. Biol Psychiatry. 1991 Jun 15; 29(12):1209-14.
Score: 0.004
-
Endocrine, cardiovascular, and behavioral effects of intravenous protirelin in patients with panic disorder. Arch Gen Psychiatry. 1991 Feb; 48(2):148-56.
Score: 0.004
-
Triiodothyronine potentiation of tricyclic antidepressant treatment in patients with panic disorder. Biol Psychiatry. 1990 Dec 15; 28(12):1061-4.
Score: 0.003
-
Patients with frequent sleep panic: clinical findings and response to medication treatment. J Clin Psychiatry. 1990 Dec; 51(12):513-6.
Score: 0.003
-
Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar; 25(2):224-31.
Score: 0.003
-
Dysequilibrium and audiovestibular function in panic disorder: symptom profiles and test findings. Am J Otol. 1990 Sep; 11(5):338-41.
Score: 0.003
-
Effect of yohimbine on plasma homovanillic acid in panic disorder patients and normal controls. Biol Psychiatry. 1990 Aug 15; 28(4):292-6.
Score: 0.003
-
Major depression in patients with panic disorder: factors associated with course and recurrence. J Affect Disord. 1990 Aug; 19(4):287-96.
Score: 0.003
-
The hypothalamic-pituitary-thyroid axis in social phobia. Am J Psychiatry. 1990 Jul; 147(7):929-33.
Score: 0.003
-
Paradoxical growth-hormone responses to thyrotropin-releasing hormone in panic disorder. Biol Psychiatry. 1990 Jun 01; 27(11):1227-30.
Score: 0.003
-
Major depression in patients with social phobia. Am J Psychiatry. 1990 May; 147(5):637-9.
Score: 0.003
-
Effects of thyrotropin-releasing hormone on blood pressure and heart rate in phobic and panic patients: a pilot study. Biol Psychiatry. 1990 Apr 01; 27(7):781-3.
Score: 0.003
-
Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder. Psychoneuroendocrinology. 2010 Aug; 35(7):1001-7.
Score: 0.003
-
Anxiety disorders in patients with Parkinson's disease. Am J Psychiatry. 1990 Feb; 147(2):217-20.
Score: 0.003
-
Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls. Psychoneuroendocrinology. 1990; 15(4):253-9.
Score: 0.003
-
Thyrotropin and prolactin responses to protirelin (TRH) prior to and during chronic imipramine treatment in patients with panic disorder. Psychoneuroendocrinology. 1990; 15(5-6):381-9.
Score: 0.003
-
Inefficacy of single-dose nifedipine in the treatment of phobic anxiety. Isr J Psychiatry Relat Sci. 1990; 27(2):119-23.
Score: 0.003
-
Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls. Psychoneuroendocrinology. 1990; 15(3):217-24.
Score: 0.003
-
Normal serum cholesterol in panic disorder. Biol Psychiatry. 1990 Jan 01; 27(1):99-101.
Score: 0.003
-
Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. Am J Psychiatry. 1989 Oct; 146(10):1299-303.
Score: 0.003
-
Sleep panic attacks: new clinical findings and theoretical implications. Am J Psychiatry. 1989 Sep; 146(9):1204-7.
Score: 0.003
-
Depersonalization disorder: effects of caffeine and response to pharmacotherapy. Biol Psychiatry. 1989 Jul; 26(3):315-20.
Score: 0.003
-
A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry. 2009 Apr 21; 70(5):699-705.
Score: 0.003
-
Infrequent occurrence of EEG abnormalities in panic disorder. Am J Psychiatry. 1989 Apr; 146(4):517-20.
Score: 0.003
-
Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry. 1989 Feb; 46(2):170-7.
Score: 0.003
-
Social phobic symptoms in patients with panic disorder: practical and theoretical implications. Am J Psychiatry. 1989 Feb; 146(2):235-8.
Score: 0.003
-
Autoimmune thyroiditis and panic disorder. Am J Psychiatry. 1989 Feb; 146(2):259-60.
Score: 0.003
-
Electroencephalographic sleep in panic disorder. A focus on sleep-related panic attacks. Arch Gen Psychiatry. 1989 Feb; 46(2):178-84.
Score: 0.003
-
Neuroendocrine effects of diazepam in normal subjects following brief painful stress. J Clin Psychopharmacol. 1988 Oct; 8(5):331-5.
Score: 0.003
-
Lack of efficacy of carbamazepine in the treatment of panic disorder. Am J Psychiatry. 1988 Sep; 145(9):1104-9.
Score: 0.003
-
Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Biol Psychiatry. 1988 Jul; 24(3):322-30.
Score: 0.003
-
Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry. 1988 Jul; 145(7):844-8.
Score: 0.003
-
Panic disorder and major depression. A tale of two syndromes. Psychiatr Clin North Am. 1988 Jun; 11(2):441-61.
Score: 0.003
-
Thyroid indices in panic disorder. Am J Psychiatry. 1988 Jun; 145(6):745-7.
Score: 0.003
-
Routine screening of thyroid indices in patients with panic attacks. J Clin Psychiatry. 1988 May; 49(5):204-5.
Score: 0.003
-
Controlled study of verapamil for treatment of panic disorder. Am J Psychiatry. 1988 Apr; 145(4):431-4.
Score: 0.003
-
Sexual dysfunction related to alprazolam treatment of social phobia. Am J Psychiatry. 1988 Apr; 145(4):531-2.
Score: 0.003
-
Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol Psychiatry. 1988 Mar 15; 23(6):575-85.
Score: 0.003
-
Ventricular-brain ratio and life course of illness in patients with affective disorder. Psychiatry Res. 1988 Mar; 23(3):277-84.
Score: 0.003
-
Exogenous factors in panic disorder: clinical and research implications. J Clin Psychiatry. 1988 Feb; 49(2):56-61.
Score: 0.003
-
Obsessive-compulsive symptoms in panic disorder. Am J Psychiatry. 1987 Dec; 144(12):1573-6.
Score: 0.003
-
Plasma adenosine levels: measurement in humans and relationship to the anxiogenic effects of caffeine. Psychiatry Res. 1987 Jul; 21(3):247-55.
Score: 0.003
-
Cerebral ventricular size in panic disorder. J Affect Disord. 1987 Mar-Apr; 12(2):175-8.
Score: 0.003
-
[Acute anxiety attacks and phobia. Historical aspects and clinical manifestations of the agoraphobia syndrome]. Ann Med Psychol (Paris). 1987 Feb; 145(2):113-31.
Score: 0.003
-
Life events obtained via interview: the effect of time of recall on data obtained in controls and patients with panic disorder. J Affect Disord. 1987 Jan-Feb; 12(1):57-62.
Score: 0.003
-
Platelet [3H]imipramine binding in patients with panic disorder. Biol Psychiatry. 1987 Jan; 22(1):52-8.
Score: 0.003
-
Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. CNS Drugs. 2007; 21(1):47-71.
Score: 0.003
-
Withdrawal syndrome with gradual tapering of alprazolam. Am J Psychiatry. 1986 Nov; 143(11):1464-6.
Score: 0.003
-
Life events and the onset of panic disorder. Am J Psychiatry. 1986 Nov; 143(11):1424-7.
Score: 0.003
-
Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry. 1986 Sep; 21(11):1081-5.
Score: 0.003
-
Life events and course of illness in patients with panic disorder. Am J Psychiatry. 1986 Aug; 143(8):1033-5.
Score: 0.003
-
Effect of carbamazepine on body weight in affectively ill patients. J Clin Psychiatry. 1986 Jun; 47(6):313-4.
Score: 0.003
-
Effects of carbamazepine on serum electrolytes in affectively ill patients. Psychol Med. 1986 May; 16(2):331-5.
Score: 0.003
-
Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness. Psychopharmacology (Berl). 1986; 88(1):115-8.
Score: 0.002
-
Are the psychotropic effects of carbamazepine in manic-depressive illness mediated through the limbic system? Psychiatr J Univ Ott. 1985 Dec; 10(4):205-19.
Score: 0.002
-
Differential diagnosis and treatment of panic disorder: a medical model perspective. Aust N Z J Psychiatry. 1985 Dec; 19(4):330-41.
Score: 0.002
-
The dexamethasone suppression test in panic disorder: comparison with normal controls. Biol Psychiatry. 1985 Nov; 20(11):1237-40.
Score: 0.002
-
NIMH report. Current perspectives on panic disorder and agoraphobia. Hosp Community Psychiatry. 1985 Nov; 36(11):1153-4.
Score: 0.002
-
Hematological effects of carbamazepine in patients with affective illness. Am J Psychiatry. 1985 Oct; 142(10):1196-9.
Score: 0.002
-
Decreased triiodothyronines in depression: a preliminary report. Biol Psychiatry. 1985 Aug; 20(8):922-5.
Score: 0.002
-
Caffeine-induced escape from dexamethasone suppression. Arch Gen Psychiatry. 1985 Jul; 42(7):737-8.
Score: 0.002
-
Lack of pharmacokinetic interaction of carbamazepine with tranylcypromine. Arch Gen Psychiatry. 1985 Jul; 42(7):738.
Score: 0.002
-
Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol Psychiatry. 2005 Feb 01; 57(3):210-9.
Score: 0.002
-
Relationship between cerebrospinal fluid somatostatin and peripheral thyroid hormones with carbamazepine treatment. Neuropsychobiology. 1985; 14(3):115-7.
Score: 0.002
-
Carbamazepine in bipolar illness. Psychopharmacol Bull. 1985; 21(1):10-7.
Score: 0.002
-
Panic disorder and major depression: biological relationships. Psychopharmacol Bull. 1985; 21(3):551-4.
Score: 0.002
-
Effects of caffeine on heart rate and QT variability during sleep. Depress Anxiety. 2005; 22(3):150-5.
Score: 0.002
-
Glucose tolerance testing in panic disorder. Am J Psychiatry. 1984 Nov; 141(11):1461-3.
Score: 0.002
-
Lithium increases platelet count. N Engl J Med. 1984 Sep 06; 311(10):674-5.
Score: 0.002
-
The sleep of patients with panic disorder: a preliminary report. Psychiatry Res. 1984 Jul; 12(3):251-9.
Score: 0.002
-
New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol Psychiatry. 1984 Feb; 19(2):131-56.
Score: 0.002
-
Carbamazepine and lithium carbonate synergism in mania. Arch Gen Psychiatry. 1984 Feb; 41(2):210.
Score: 0.002
-
Caffeine: relationship to human anxiety, plasma MHPG and cortisol. Psychopharmacol Bull. 1984; 20(3):426-30.
Score: 0.002
-
Biochemical mechanisms of action of carbamazepine in affective illness and epilepsy. Psychopharmacol Bull. 1984; 20(3):585-9.
Score: 0.002
-
Neuroendocrine and peptide effects of carbamazepine: clinical and mechanistic implications. Psychopharmacol Bull. 1984; 20(3):590-4.
Score: 0.002
-
Fear and anxiety: relationship to noradrenergic function. Psychopathology. 1984; 17 Suppl 3:8-23.
Score: 0.002
-
Alprazolam-related hepatotoxicity. Lancet. 1983 Oct 01; 2(8353):786-7.
Score: 0.002
-
Effects of carbamazepine on serum electrolytes: clinical and theoretical implications. J Clin Psychopharmacol. 1983 Apr; 3(2):103-6.
Score: 0.002
-
[Treatment of panic attacks]. Encephale. 1983; 9(4 Suppl 2):299B-305B.
Score: 0.002
-
Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications. Epilepsia. 1983; 24 Suppl 2:S97-108.
Score: 0.002
-
[Biochemical aspects of anxiety]. Sem Hop. 1982 Dec 02; 58(44):2573-9.
Score: 0.002
-
The relationship of plasma free MHPG to anxiety and psycho-physical pain in normal volunteers. Psychopharmacol Bull. 1982 Oct; 18(4):129-32.
Score: 0.002
-
Animal models of anxiety: implications for research in humans. Psychopharmacol Bull. 1982 Oct; 18(4):47-52.
Score: 0.002
-
Caffeine consumption and anxiety: preliminary results of a survey comparing patients with anxiety disorders and normal controls. Psychopharmacol Bull. 1982 Oct; 18(4):53-7.
Score: 0.002
-
Psychosis in the opioid addicted patient: assessment and treatment. J Clin Psychiatry. 1982 Jun; 43(6):240-7.
Score: 0.002
-
Biological relationships between mania and melancholia. Encephale. 1982; 8(2):213-28.
Score: 0.002
-
Biological peripheral correlates of anxiety. Encephale. 1982; 8(2):119-30.
Score: 0.002
-
Noradrenergic challenges in the affective disorders. J Clin Psychopharmacol. 1981 Jul; 1(4):193-206.
Score: 0.002
-
Clonidine and psychophysical pain. Lancet. 1980 Dec 20-27; 2(8208-8209):1375.
Score: 0.002
-
Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study. Psychiatry Res. 1980 Mar; 2(1):37-47.
Score: 0.002
-
Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders. Biol Psychiatry. 1998 Nov 15; 44(10):998-1006.
Score: 0.002
-
Effects of intravenous caffeine administered to healthy males during sleep. Depress Anxiety. 1997; 5(1):21-8.
Score: 0.001
-
Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994 May 19; 330(20):1411-7.
Score: 0.001
-
Fluoxetine for the treatment of social phobia. J Clin Psychopharmacol. 1992 Aug; 12(4):293-5.
Score: 0.001
-
Viscosity and social cohesion in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 1992 Feb; 55(2):149-52.
Score: 0.001
-
Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry. 1991 Oct; 48(10):938-45.
Score: 0.001
-
Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology. 1990 Aug; 3(4):261-72.
Score: 0.001
-
Dysphoric mania. Clinical and biological correlates. Arch Gen Psychiatry. 1989 Apr; 46(4):353-8.
Score: 0.001
-
Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical implications. Psychiatry Res. 1987 Sep; 22(1):11-9.
Score: 0.001
-
Motor activity in depressed patients treated with carbamazepine. Biol Psychiatry. 1987 Aug; 22(8):941-6.
Score: 0.001
-
Correlates of antimanic response to carbamazepine. Psychiatry Res. 1987 May; 21(1):71-83.
Score: 0.001
-
Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. Biol Psychiatry. 1987 May; 22(5):545-53.
Score: 0.001
-
Effects of diazepam on cognitive processes in normal subjects. Psychopharmacology (Berl). 1987; 91(1):30-3.
Score: 0.001
-
Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controls. Arch Gen Psychiatry. 1986 Sep; 43(9):895-9.
Score: 0.001
-
Indices of noradrenergic output in depression. Psychiatry Res. 1986 Sep; 19(1):59-73.
Score: 0.001
-
Clonidine reduces plasma melatonin levels. J Pharm Pharmacol. 1986 Jul; 38(7):555-6.
Score: 0.001
-
The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry. 1986 Jul; 143(7):896-9.
Score: 0.001
-
Plasma HVA and anxiety in patients with panic disorder. Biol Psychiatry. 1986 Jul; 21(8-9):849-53.
Score: 0.001
-
Reduced TSH and prolactin responses to TRH in patients with panic disorder. Am J Psychiatry. 1986 Apr; 143(4):503-7.
Score: 0.001
-
Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness. Arch Gen Psychiatry. 1986 Apr; 43(4):392-6.
Score: 0.001
-
Alpha 2-adrenergic receptor function in patients with unipolar and bipolar affective disorders. J Affect Disord. 1986 Mar-Apr; 10(2):163-9.
Score: 0.001
-
Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. Am J Psychiatry. 1986 Feb; 143(2):235-6.
Score: 0.001
-
Antidepressant effects of carbamazepine. Am J Psychiatry. 1986 Jan; 143(1):29-34.
Score: 0.001
-
Carbamazepine treatment of mania: clinical and biochemical aspects. Clin Neuropharmacol. 1986; 9 Suppl 4:547-9.
Score: 0.001
-
Biological alterations in the primary affective disorders and other tricyclic-responsive disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(1):15-24.
Score: 0.001
-
Platelet alpha-adrenergic receptor function in affective disorders and schizophrenia. Psychopharmacol Bull. 1985; 21(3):599-602.
Score: 0.001
-
Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients. Psychopharmacology (Berl). 1985; 87(1):59-63.
Score: 0.001
-
Normal pain sensitivity in patients with panic disorder. Psychiatry Res. 1985 Jan; 14(1):77-84.
Score: 0.001
-
The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl. 1985; 317:1-34.
Score: 0.001
-
Neuroendocrine abnormalities in panic disorder. Psychopharmacol Bull. 1985; 21(3):546-50.
Score: 0.001
-
Longitudinal course of panic disorder: clinical and biological considerations. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(1):39-51.
Score: 0.001
-
Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications. Arch Gen Psychiatry. 1984 Dec; 41(12):1150-3.
Score: 0.001
-
Approaches to the evaluation and treatment of rapid-cycling affective illness. Br J Psychiatry. 1984 Nov; 145:543-50.
Score: 0.001
-
Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Arch Gen Psychiatry. 1984 Nov; 41(11):1067-71.
Score: 0.001
-
Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study. J Clin Psychopharmacol. 1984 Aug; 4(4):178-85.
Score: 0.001
-
Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. Am J Psychiatry. 1984 Jun; 141(6):733-41.
Score: 0.001
-
The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone. Psychiatry Res. 1984 Jun; 12(2):161-6.
Score: 0.001
-
Relationship of response to sleep deprivation and carbamazepine in depressed patients. Acta Psychiatr Scand. 1984 May; 69(5):379-82.
Score: 0.001
-
Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite. Acta Psychiatr Scand Suppl. 1984; 313:104-20.
Score: 0.001
-
The efficacy of carbamazepine in affective illness. Adv Biochem Psychopharmacol. 1984; 39:421-37.
Score: 0.001
-
Plasma cortisol responses to clonidine in depressed patients and controls. Evidence for a possible alteration in noradrenergic-neuroendocrine relationships. Arch Gen Psychiatry. 1984 Jan; 41(1):63-8.
Score: 0.001
-
Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry. 1983 Dec; 140(12):1602-4.
Score: 0.001
-
Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry. 1983 Jun; 40(6):673-6.
Score: 0.001
-
Extreme elevations in plasma norepinephrine associated with decreased alpha-adrenergic responsiveness in major depressive disorder: two case reports. J Clin Psychopharmacol. 1983 Feb; 3(1):39-41.
Score: 0.001
-
Growth hormone response to clonidine in obsessive-compulsive patients. Br J Psychiatry. 1983 Feb; 142:184-7.
Score: 0.001
-
Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):263-71.
Score: 0.001
-
Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):249-61.
Score: 0.001
-
Abnormalities in the primary affective disorders compared to other tricyclic-responsive disorders. Psychopharmacol Bull. 1983; 19(3):435-6.
Score: 0.001
-
Kindling and carbamazepine in affective illness. J Nerv Ment Dis. 1982 Dec; 170(12):717-31.
Score: 0.000
-
Evaluation of alpha-adrenergic responsiveness to clonidine challenge and noradrenergic metabolism in the affective disorders and their treatment. Psychopharmacol Bull. 1982 Oct; 18(4):118-9.
Score: 0.000
-
Growth hormone response to clonidine unchanged by chronic clorgyline treatment. Psychiatry Res. 1982 Oct; 7(2):139-44.
Score: 0.000
-
Melatonin secretion as a neurobiological "marker" and effects of light in humans. Psychopharmacol Bull. 1982 Oct; 18(4):127-9.
Score: 0.000
-
Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol Psychiatry. 1982 Sep; 17(9):1037-45.
Score: 0.000
-
Possible subsensitization of alpha 2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatry Res. 1982 Jun; 6(3):293-302.
Score: 0.000
-
Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Res. 1982 Apr; 6(2):171-83.
Score: 0.000
-
Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response. Psychiatry Res. 1981 Aug; 5(1):59-66.
Score: 0.000
-
Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases. Commun Psychopharmacol. 1980; 4(6):477-86.
Score: 0.000